Literature DB >> 26272194

A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage.

Christophe Meune1, Dinesh Khanna2, Jamil Aboulhosn3, Jérôme Avouac4, André Kahan5, Daniel E Furst3, Yannick Allanore5.   

Abstract

OBJECTIVE: Heart involvement in systemic sclerosis (SSc) is a strong prognostic factor. Our aim was to examine left ventricle (LV) and right ventricle (RV) involvement.
METHODS: We examined LV and RV, systolic and diastolic functions, using echocardiography and Tissue-Doppler echocardiography (TDE) indexes, in a cohort of 212 consecutive SSc patients seen during a 9-month period at 2 institutions (Paris, France and Los Angeles, USA). They were compared to 50 healthy controls.
RESULTS: When compared to controls, SSc patients had consistently impaired RV indices that include reduced RV contractility (p < 0.001), larger right atrial area (p = 0.027) and overall RV diastolic dysfunction (25% of SSc patients versus 0% of controls; p < 0.001). Patients also exhibited alterations in LV contractility and diastolic function (p < 0.001 each). In multivariate analysis, RV contractility as expressed by the TDE S(T) parameter was associated with TDE LV contractility S(M) (p = 0.030), DLCO (p = 0.013) whereas RV diastolic impairment was associated with systolic pulmonary artery pressure (p = 0.015). A subgroup of 27 patients had proven pulmonary arterial hypertension (PAH); comparison between SSc-PAH versus SSc free of PAH patients revealed reduced LV diastolic function (transmitral E/A ratio, p = 0.045 and E(A) < 10 cm/s, p = 0.029), reduced overall RV contractility (21.5% versus 4.5%; p = 0.03) and reduced RV diastolic function (transtricuspid E/A ratio; p = 0.014 and 68% versus 29% with impaired function; p = 0.001).
CONCLUSIONS: Our data show that RV is commonly affected in SSc with predominant impaired diastolic function. Several factors, including primary heart, lung vascular disease and pulmonary hypertension, contribute to such impairment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Diastolic dysfunction; Echocardiography; Myocardial involvement; Right ventricle; Systemic sclerosis

Mesh:

Year:  2015        PMID: 26272194     DOI: 10.1016/j.semarthrit.2015.07.002

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  9 in total

1.  CT compared to MRI for functional evaluation of the right ventricle: a systematic review and meta-analysis.

Authors:  Hang Fu; Xuedong Wang; Kaiyue Diao; Shan Huang; Hui Liu; Yue Gao; Qin Zhao; Zhi-Gang Yang; Ying-Kun Guo
Journal:  Eur Radiol       Date:  2019-05-27       Impact factor: 5.315

2.  Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study.

Authors:  Michele D'Alto; Antonella Riccardi; Paola Argiento; Ilaria Di Stefano; Emanuele Romeo; Agostino Mattera Iacono; Antonello D'Andrea; Serena Fasano; Alessandro Sanduzzi; Marialuisa Bocchino; Ludovico Docimo; Salvatore Tolone; Maria Giovanna Russo; Gabriele Valentini
Journal:  Clin Exp Med       Date:  2017-10-09       Impact factor: 3.984

3.  Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension.

Authors:  Amber Young; Vivek Nagaraja; Mark Basilious; Mirette Habib; Whitney Townsend; Heather Gladue; David Badesch; J Simon R Gibbs; Deepa Gopalan; Alessandra Manes; Ronald Oudiz; Toru Satoh; Adam Torbicki; Fernando Torres; Vallerie McLaughlin; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2018-10-14       Impact factor: 5.532

Review 4.  Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.

Authors:  George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee
Journal:  Curr Rheumatol Rep       Date:  2019-12-07       Impact factor: 4.592

5.  A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohort.

Authors:  Rebecca S Overbury; Maureen A Murtaugh; Tracy M Frech; Virginia D Steen
Journal:  J Scleroderma Relat Disord       Date:  2018-06-01

Review 6.  Update on assessment and management of primary cardiac involvement in systemic sclerosis.

Authors:  Vasiliki-Kalliopi Bournia; Christos Tountas; Athanase D Protogerou; Stylianos Panopoulos; Sophie Mavrogeni; Petros P Sfikakis
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

7.  Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications.

Authors:  Anders H Tennøe; Klaus Murbræch; Johanna C Andreassen; Håvard Fretheim; Øyvind Midtvedt; Torhild Garen; Håvard Dalen; Einar Gude; Arne Andreassen; Svend Aakhus; Øyvind Molberg; Anna-Maria Hoffmann-Vold
Journal:  ACR Open Rheumatol       Date:  2019-05-31

Review 8.  Cardiovascular Imaging for Systemic Sclerosis Monitoring and Management.

Authors:  Peter Glynn; Sarah Hale; Tasmeen Hussain; Benjamin H Freed
Journal:  Front Cardiovasc Med       Date:  2022-03-31

Review 9.  Management of systemic sclerosis: the first five years.

Authors:  David Roofeh; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2020-05       Impact factor: 4.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.